Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. (Q36512532)
Jump to navigation
Jump to search
scientific article published on 18 September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. |
scientific article published on 18 September 2012 |
Statements
Cetuximab-mediated tumor regression depends on innate and adaptive immune responses (English)
Xunmin Zhang
Eric D Mortenson
Olga Radkevich-Brown
18 September 2012
1 reference
1 reference